Agents Acting on the Renin-angiotensin System
Agents Acting on the Renin-angiotensin System Companies (5)
Agents Acting on the Renin-angiotensin System Products (4)
-
Product Generic (Irbesartan + HCTZ)
- Active substance(s): Irbesartan + HCTZ;
- Pharmaceutical form(s): Tablets
- Strength(s): 150 + 12,5 mg; 300 + 12,5 mg; 300 + 25 mg -
Product Generic (Losartan)
- Active substance(s): Losartan;
- Pharmaceutical form(s): Tablets
- Strength(s): 50 mg; 100 mg -
Product Generic (Olmesartan Medoximil)
- Active substance(s): Olmesartan Medoximil;
- Pharmaceutical form(s): Tablets
- Strength(s): 20 mg; 40 mg -
Product Generic (Olmesartan Medoximil + HCTZ)
- Active substance(s): Olmesartan Medoximil + HCTZ;
- Pharmaceutical form(s): Tablets
- Strength(s): 20 mg + 12,5 mg; 40 mg + 12,5 mg; 40 mg + 25 mg
Upcoming Events
-
CPHI Japan 2023
Tokyo Big Sight, Tokyo, Japan
19 - 21 April 2023 -
CPHI North America 2023
Pennsylvania Convention Center, Philadelphia
April, 25-27, 2023 -
CPHI & PMEC China 2023
Shanghai New International Expo Center
19 - 21 June 2023
Pharmaceutical Industry Webinars
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance